Literature DB >> 7494311

Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally.

A M Amedee1, N Lacour, J L Gierman, L N Martin, J E Clements, R Bohm, R M Harrison, M Murphey-Corb.   

Abstract

To understand viral and host factors that contribute to transplacental transmission of human immunodeficiency virus, we developed an animal model using pregnant female macaques infected with simian immunodeficiency virus (SIV). Pregnant females were inoculated intravenously during midgestation with either a well-characterized primary isolate of SIV (SIV/DeltaB670) or a combination of SIV/DeltaB670 and the macrophage-tropic molecular clone SIV/17E-Fr. The viral genetic diversity in five infected female macaques and their in utero-infected infants was analyzed. All of the mothers harbored a genetically diverse virus population at parturition, whereas a single genotype from the maternal quasispecies was identified in the infants at birth. Only one of two variants was found in the infants: SIV/17E-Fr (two cases) or a genotype contained within the SIV/DeltaB670 quasispecies (three cases). The macrophage-tropic properties of both transmitted genotypes were suggested by productive replication in primary rhesus macrophage cultures in vitro and the clonal presence in central nervous system tissue of infected monkeys with encephalitis. These observations provide compelling evidence for both genotypic and phenotypic selection in transplacental transmission of SIV and suggest a critical role for macrophages in fetal infection in utero.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494311      PMCID: PMC189743     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Experimental infection of timed-pregnant rhesus monkeys with simian immunodeficiency virus (SIV) during early, middle, and late gestation.

Authors:  B Davison-Fairburn; J Blanchard; F S Hu; L Martin; R Harrison; M Ratterree; M Murphey-Corb
Journal:  J Med Primatol       Date:  1990       Impact factor: 0.667

2.  Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates.

Authors:  J L Spouge
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS.

Authors:  J Overbaugh; L M Rudensey; M D Papenhausen; R E Benveniste; W R Morton
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques.

Authors:  D P Sharma; M C Zink; M Anderson; R Adams; J E Clements; S V Joag; O Narayan
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques.

Authors:  M G Anderson; D Hauer; D P Sharma; S V Joag; O Narayan; M C Zink; J E Clements
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

6.  Survival in children with perinatally acquired human immunodeficiency virus type 1 infection.

Authors:  G B Scott; C Hutto; R W Makuch; M T Mastrucci; T O'Connor; C D Mitchell; E J Trapido; W P Parks
Journal:  N Engl J Med       Date:  1989-12-28       Impact factor: 91.245

7.  Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.

Authors:  S M Wolinsky; C M Wike; B T Korber; C Hutto; W P Parks; L L Rosenblum; K J Kunstman; M R Furtado; J L Muñoz
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

8.  Maternal-fetal transmission of SIV in macaques: disseminated adenovirus infection in an offspring with congenital SIV infection.

Authors:  H D Ochs; W R Morton; C C Tsai; M E Thouless; Q Zhu; L D Kuller; Y P Wu; R E Benveniste
Journal:  J Med Primatol       Date:  1991-06       Impact factor: 0.667

9.  Simian immunodeficiency virus infection via amniotic fluid: a model to study fetal immunopathogenesis and prophylaxis.

Authors:  F Fazely; P L Sharma; C Fratazzi; M F Greene; M S Wyand; M A Memon; D Penninck; R M Ruprecht
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-02

10.  Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers.

Authors:  G Scarlatti; T Leitner; E Halapi; J Wahlberg; P Marchisio; M A Clerici-Schoeller; H Wigzell; E M Fenyö; J Albert; M Uhlén
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more
  37 in total

1.  Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.

Authors:  A L Edinger; M Ahuja; T Sung; K C Baxter; B Haggarty; R W Doms; J A Hoxie
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain.

Authors:  Tahar Babas; Daniel Muñoz; Joseph L Mankowski; Patrick M Tarwater; Janice E Clements; M Christine Zink
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Shortening of the symptom-free period in rhesus macaques is associated with decreasing nonsynonymous variation in the env variable regions of simian immunodeficiency virus SIVsm during passage.

Authors:  P J Valli; V V Lukashov; J L Heeney; J Goudsmit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

4.  Structured-tree topology and adaptive evolution of the simian immunodeficiency virus SIVsm envelope during serial passage in rhesus macaques according to likelihood mapping and quartet puzzling.

Authors:  P J Valli; J Goudsmit
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease.

Authors:  J A Lednicky; A S Arrington; A R Stewart; X M Dai; C Wong; S Jafar; M Murphey-Corb; J S Butel
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection.

Authors:  L A Chakrabarti; S R Lewin; L Zhang; A Gettie; A Luckay; L N Martin; E Skulsky; D D Ho; C Cheng-Mayer; P A Marx
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.

Authors:  Deborah Heydenburg Fuller; Premeela A Rajakumar; Lawrence A Wilson; Anita M Trichel; James T Fuller; Tim Shipley; Mary S Wu; Kathleen Weis; Charles R Rinaldo; Joel R Haynes; Michael Murphey-Corb
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  Characterization of cells expressing lymphatic marker LYVE-1 in macaque large intestine during simian immunodeficiency virus infection identifies a large population of nonvascular LYVE-1(+)/DC-SIGN(+) cells.

Authors:  Yang-Kyu Choi; Beth A Fallert Junecko; Cynthia R Klamar; Todd A Reinhart
Journal:  Lymphat Res Biol       Date:  2013-03       Impact factor: 2.589

9.  Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters.

Authors:  Niraj C Patel; Steven J Halvorson; Vojtech Sroller; Amy S Arrington; Connie Wong; E O'Brian Smith; Regis A Vilchez; Janet S Butel
Journal:  Virology       Date:  2009-01-31       Impact factor: 3.616

10.  Altered immune responses in rhesus macaques co-infected with SIV and Plasmodium cynomolgi: an animal model for coincident AIDS and relapsing malaria.

Authors:  Jeffrey W Koehler; Michael Bolton; Amanda Rollins; Kirsten Snook; Eileen deHaro; Elizabeth Henson; Linda Rogers; Louis N Martin; Donald J Krogstad; Mark A James; Janet Rice; Billie Davison; Ronald S Veazey; Ramesh Prabhu; Angela M Amedee; Robert F Garry; Frank B Cogswell
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.